Published in Lancet on December 29, 1973
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry (2001) 2.50
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain (2006) 2.00
Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry (1986) 1.83
Progressive language disorder due to lobar atrophy. Ann Neurol (1992) 1.82
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Sub-clinical entrapment neuropathy in man. J Neurol Sci (1975) 1.78
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry (1993) 1.62
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (1999) 1.55
Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol (2002) 1.51
Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.51
Distinct neuropsychological characteristics in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2002) 1.48
Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand (2001) 1.47
Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry (1995) 1.37
Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia (2003) 1.37
Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry (1986) 1.36
Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide. Br Med J (1973) 1.36
Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain (2002) 1.32
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology (1989) 1.29
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem (1983) 1.28
Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem (1983) 1.28
Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.25
The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol (1988) 1.19
Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand (2002) 1.18
Benefit from adrenocorticotrophin in myasthenia gravis. J Neurol Neurosurg Psychiatry (1974) 1.17
Primary angiitis of the central nervous system: emerging variants. QJM (2005) 1.16
Awareness of involuntary movements in Huntington disease. Arch Neurol (1998) 1.16
Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem (1987) 1.09
Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol (1999) 1.05
Emotion recognition in Huntington's disease and frontotemporal dementia. Neuropsychologia (2008) 1.05
Progressive aphasia with right-sided extrapyramidal signs: another manifestation of localised cerebral atrophy. J Neurol Neurosurg Psychiatry (1989) 1.03
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med (1985) 1.00
Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res (1987) 1.00
Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain (1995) 0.99
Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1981) 0.98
Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet (1993) 0.98
Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem (1988) 0.97
Activation of a cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature (1982) 0.97
Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet (1980) 0.96
The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol (1995) 0.96
Treatment of polyneuropathy with azathioprine. Lancet (1970) 0.95
The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry (2006) 0.95
Icarus's syndrome: new hazards in flight. Br Med J (1977) 0.95
Alzheimer's disease as a disorder of isodendritic core. Lancet (1982) 0.94
A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry (1998) 0.94
Longitudinal evaluation of cognitive disorder in Huntington's disease. J Int Neuropsychol Soc (2001) 0.92
Deficiencies in anti-acetylcholine receptor antibody measurement in myasthenia gravis. J Neurol Neurosurg Psychiatry (1991) 0.92
The thoracic outlet syndrome. Brain (1977) 0.92
Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry (2006) 0.91
A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Br J Clin Pract (1972) 0.91
Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease. Acta Neuropathol (1992) 0.91
The cause of nerve damage in acute compression. Trans Am Neurol Assoc (1974) 0.90
Renaut body distribution at sites of human peripheral nerve entrapment. J Neurol Sci (1981) 0.90
Acute polyneuropathy complicating chronic renal failure. Nephron (1971) 0.89
Arithmetic knowledge in semantic dementia: is it invariably preserved? Neuropsychologia (2008) 0.89
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry (1984) 0.89
Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med (1994) 0.89
Clinical spectrum of neuroleptic malignant syndrome. Lancet (1988) 0.89
Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry (1995) 0.88
Non Alzheimer's disease forms of cerebral atrophy. J Neurol Neurosurg Psychiatry (1990) 0.88
A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol (1997) 0.86
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl) (2007) 0.85
Abnormalities of motor timing in Huntington's disease. Parkinsonism Relat Disord (1996) 0.85
Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease. Neuropathol Appl Neurobiol (1981) 0.84
Suppression of "rubral" tremor with levodopa. Br Med J (1980) 0.84
Pathological changes in the brain of a patient with familial Alzheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene. Neurosci Lett (1992) 0.84
Apolipoprotein E allelic frequencies in patients with lobar atrophy. Neurosci Lett (1995) 0.83
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain (1987) 0.83
Inferring thought and action in motor neurone disease. Neuropsychologia (2006) 0.83
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience (1990) 0.83
Letter: Localized hypertrophic neuropathy, intraneural tumour, or chronic nerve entrapment? Lancet (1975) 0.82
The long-term outcome of head injury: implications for service planning. Brain Inj (1995) 0.82
Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology. Exp Neurol (2000) 0.82
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J Neurol Neurosurg Psychiatry (2006) 0.81
Neuropsychiatric aspects of frontotemporal dementias. Curr Psychiatry Rep (1999) 0.81
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease. Brain Res (1983) 0.81
Actinomycin-D treatment in a case of acute intermittent porphyria. Lancet (1970) 0.81
Autopsy proven sporadic frontotemporal dementia due to microvacuolar-type histology, with onset at 21 years of age. J Neurol Neurosurg Psychiatry (2004) 0.81
An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease. Neuropathol Appl Neurobiol (1986) 0.81
Tau pathology in a case of familial Alzheimer's disease with a valine to glycine mutation at position 717 in the amyloid precursor protein. Neurosci Lett (1992) 0.80
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease. Brain Res (1987) 0.80
Soluble beta-amyloid precursor protein and pyramidal neuron loss. Lancet (1993) 0.80
Somatostatin content and release measured in cerebral biopsies from demented patients. J Neurol Sci (1987) 0.80
Long term memory for famous voices in amnesic and normal subjects. Neuropsychologia (1980) 0.80
Autobiographical experience and word meaning. Memory (1996) 0.79
Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry (1993) 0.79
Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias. Acta Neurol Scand (2002) 0.79
Megaloblastic anaemia due to trimethoprim-sulphamethoxazole therapy in uraemia. Postgrad Med J (1973) 0.79
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry (1985) 0.79
Do amnesics adopt inefficient encoding strategies with faces and random shapes? Neuropsychologia (1980) 0.79
Coexistence of systemic sclerosis and multiple sclerosis. J Neurol (2004) 0.78
Progressive language dysfunction and lobar atrophy. Dementia (1993) 0.78
Idoxuridine and motor neurone disease. Br Med J (1970) 0.78
Abetalipoproteinaemia. A case report with pathological studies. Postgrad Med J (1976) 0.78
A quantitative study of the ultrastructure of pyramidal neurons of the cerebral cortex in Alzheimer's disease in relationship to the degree of dementia. Neuropathol Appl Neurobiol (1986) 0.78
DNA repair in lymphocytes from young and old individuals and from patients with Alzheimer's disease. Mutat Res (1987) 0.78
Treatment of Alzheimer's disease: a cautionary note. N Engl J Med (1981) 0.77
Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex. J Neurochem (1983) 0.77
Congenital non-progressive peripheral neuropathy with arthrogryposis multiplex. J Neurol Neurosurg Psychiatry (1974) 0.77